BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 17420266)

  • 1. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
    J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A distinct signaling pathway used by the IgG-containing B cell antigen receptor.
    Wakabayashi C; Adachi T; Wienands J; Tsubata T
    Science; 2002 Dec; 298(5602):2392-5. PubMed ID: 12493916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
    Tedder TF; Poe JC; Haas KM
    Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
    Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
    Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
    Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
    Lund FE; Yu N; Kim KM; Reth M; Howard MC
    J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
    Toda M; Akita K; Inoue M; Taketani S; Nakada H
    Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BASH-deficient mice: limited primary repertoire and antibody formation, but sufficient affinity maturation and memory B cell generation, in anti-NP response.
    Yamamoto M; Nojima T; Hayashi K; Goitsuka R; Furukawa K; Azuma T; Kitamura D
    Int Immunol; 2004 Aug; 16(8):1161-71. PubMed ID: 15237108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory.
    Martin SW; Goodnow CC
    Nat Immunol; 2002 Feb; 3(2):182-8. PubMed ID: 11812996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
    Rui L; Vinuesa CG; Blasioli J; Goodnow CC
    Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response.
    Vora KA; Ravetch JV; Manser T
    J Immunol; 1997 Sep; 159(5):2116-24. PubMed ID: 9278297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N; King CA; Vitetta ES; Stevenson FK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced capture of extramembranous IgM and IgG on B cells in the NOD mouse--implications for immune complex trapping.
    Ekici R; Sundström M; Thay B; Lejon K
    Int Immunol; 2009 May; 21(5):533-41. PubMed ID: 19299625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
    Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.
    Chen J; McLean PA; Neel BG; Okunade G; Shull GE; Wortis HH
    Nat Immunol; 2004 Jun; 5(6):651-7. PubMed ID: 15133509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the extracellular and transmembrane domain of Ig-alpha/beta in assembly of the B cell antigen receptor (BCR).
    Dylke J; Lopes J; Dang-Lawson M; Machtaler S; Matsuuchi L
    Immunol Lett; 2007 Sep; 112(1):47-57. PubMed ID: 17675166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD22 serves as a receptor for soluble IgM.
    Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
    Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirection of B cell responsiveness by transforming growth factor beta receptor.
    Roes J; Choi BK; Cazac BB
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.